ADCT
ADC Therapeutics SA
$3.07
-$0.18(-5.54%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$356.62M
Volume
262.00K
52W Range
$1.05 - $3.97
Target Price
$8.20
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $-246.3M | $33.9M | $209.9M | $69.6M | $70.8M | ||
| Total Revenue | $-246.3M | $33.9M | $209.9M | $69.6M | $70.8M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $-219.3M | $1.4M | $3.3M | $2.5M | $5.9M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $219.3M | $32.5M | $206.6M | $67.0M | $64.9M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $219.3M | $312.6M | $329.6M | $233.0M | $195.5M | ||
| Research & Development | $142.0M | $158.0M | $187.9M | $127.1M | $109.6M | ||
| Research Expense | $142.0M | $158.0M | $187.9M | $127.1M | $109.6M | ||
| Selling, General & Administrative | $77.2M | $136.2M | $141.1M | $105.9M | $85.9M | ||
| Selling & Marketing Expenses | $22.1M | $64.8M | $69.1M | $57.5M | $44.0M | ||
| General & Administrative Expenses | $55.1M | $71.5M | $72.0M | $48.4M | $41.9M | ||
| Salaries & Wages | $-96.0M | $18.3M | $-153.0M | $209.0K | $455.0K | ||
| Depreciation & Amortization | $-1.4M | $-1.7M | $-1.5M | $1.2M | $1.3M | ||
| Depreciation & Amortization | $-1.2M | $18.3M | $-1.2M | $1.2M | $1.3M | ||
| Amortization | $-263.0K | $-129.0K | $-344.0K | -- | -- | ||
| Other Operating Expenses | -- | -- | $-31.0K | $-1.5M | $-1.3M | ||
| OPERATING INCOME | |||||||
| Operating income | $-219.3M | $-280.1M | $-123.6M | $-166.0M | $-130.7M | ||
| EBITDA | $-492.3M | $-481.4M | $-107.7M | $-132.1M | $-76.0M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | -- | -- | $36.7M | $46.3M | $50.2M | ||
| Intinc | $832.0K | $66.0K | $18.0M | $10.5M | $12.3M | ||
| Net Non-Operating Interest Income/Expense | $-245.5M | $66.0K | $34.2M | $10.5M | $12.3M | ||
| Gain on Sale of Securities | -- | -- | $-155.8M | -- | -- | ||
| Other Income/Expense | $27.5M | $201.5M | $10.3M | $-824.0K | $-10.9M | ||
| Other Special Charges | $433.2M | $56.1M | $1.8M | $6.4M | $12.5M | ||
| SPECIAL ITEMS | |||||||
| Special Income Charges | $216.0K | -- | $1.7M | -- | -- | ||
| Impairment of Capital Assets | $-216.0K | -- | $-1.7M | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-492.3M | $-481.5M | $-110.1M | $-154.6M | $-107.5M | ||
| Pre-Tax Income | $-492.3M | $-481.5M | $-146.8M | $-195.4M | $-156.1M | ||
| INCOME TAX | |||||||
| Tax Provision | $327.0K | $-21.5M | $227.0K | $39.1M | $166.0K | ||
| NET INCOME | |||||||
| Net Income | $-492.6M | $-460.1M | $-157.1M | $-240.1M | $-157.8M | ||
| Net Income (Continuing Operations) | $-492.6M | $-460.1M | $-157.1M | $-240.1M | $-157.8M | ||
| Net Income (Discontinued Operations) | $-492.6M | $-460.1M | $-157.1M | $-240.1M | $-157.8M | ||
| Net Income (Common Stockholders) | $-492.6M | $-460.1M | $-157.1M | $-240.1M | $-157.8M | ||
| Normalized Income | -- | -- | -- | -- | $-154.6M | ||
| TOTALS | |||||||
| Total Expenses | -- | $314.0M | $332.9M | $235.5M | $201.5M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $130.7M | $76.7M | $78.2M | $81.7M | $97.2M | ||
| Average Shares Outstanding (Diluted) | $130.7M | $76.7M | $78.2M | $81.7M | $97.2M | ||
| Shares Outstanding | $76.7M | $76.8M | $80.6M | $82.5M | $99.1M | ||
| Basic EPS | $-3.77 | $-3 | $-1.99 | $-2.94 | $-1.62 | ||
| Basic EPS (Continuing Operations) | $-3.77 | $-3 | $-1.99 | $-2.94 | $-1.62 | ||
| Diluted EPS | $-3.77 | $-3 | $-1.99 | $-2.94 | $-1.62 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-2.94 | $-1.62 | ||
| OTHER METRICS | |||||||
| Allowances For Construction | $27.5M | $-28.5M | $12.1M | -- | -- | ||
| Diluted Discontinuous Operations | $-3.77 | $-3 | $-1.99 | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | $-5.5M | $-1.5M | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | $-5.5M | $-1.5M | ||
| Gain On Sale Of P P E | -- | $-230.0M | -- | -- | -- | ||
| Other Gand A | $55.1M | $71.5M | $72.0M | $48.4M | $41.9M | ||
| Selling Expense | $22.1M | $64.8M | $69.1M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADCT | $3.07 | -5.5% | 262.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |